Beranda › Sindrom Bronkiolitis Obliterans › North Carolina
Uji klinis Sindrom Bronkiolitis Obliterans di North Carolina
7 studi untuk Sindrom Bronkiolitis Obliterans mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Duke Eye Center - Ophthalmology, Durham
Menerima pesertaFase 3
Usia 10 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07395232A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Levine Cancer Institute, Charlotte
- Duke Cancer Center, Durham
Menerima pesertaFase 2
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Wake Forest Baptist Medical Center, Winston-Salem
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05919511A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of North Carolina At Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06615050Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Duke, Durham
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT06233110A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Levine Cancer Institute, Charlotte
- Duke University Hospital, Durham
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.